Zhang, Y., Fei, Q., Li, Y., Wang, S., Rong, T., Wu, X., Gao, H., Chen, C., Gao, D., Zhao, Y., Li, G., Chu, H., Li, W., Yang, W. (2026). An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression. Nature Communications. https://doi.org/10.1038/s41467-026-68699-4